Timothy Warbington

Creative Medical Technology Holdings, Inc. is a publicly traded commercial stage biotechnology company which was spun out from Creative Medical Health, Inc. a privately held biotechnology incubator and holding company formed by Mr. Warbington, Dr. Amit Patel and Dr. Thomas Ichim in 2011. Creative Medical Technology Holdings, Inc. trades on the OTCQB under the ticker symbol CELZ. It's area's of concentration and patent portfolio are in the field of stem cell treatments for orthopedics, urology and neurology.

CREATIVE MEDICAL HEALTH, INC. was founded in 2011 as a holding company of health related assets including intellectual property, formulas, medical protocol, patents, trademarks, agreements, contracts and wholly owned subsidiaries engaged in the licensing and marketing of Creative Medical’s assets. The area of concentration is the approximately $30 billion per year complementary and alternative medicine market in the United States and $250 billion worldwide market. Unique to this market is the relatively little scientific evidence for many of the products sold. Creative Medical is working with key opinion leaders in the field of science and medicine in researching, developing and testing treatments that can enter the market through relatively low regulatory burden and provide a “science-first” brand of products. Contrary to many conventional biotechnology firms that may rely on the sale of intellectual property and patents as a financial exit strategy only after many years of clinical trials and subject to FDA approval, Creative Medical’s multifaceted business model, specific acquisitions and product development are intended to create a cash flow which shall provide an attractive return to its shareholders and provide the resources for expansion, acquisitions and development of cutting edge technology in the areas of stem cell technology and nutraceuticals.